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Abstract 
This study aimed to investigate the possibility of modifying model 
BisGMA/TEGDMA dental composite by substituting 10 wt. % of conventional glass 
fillers with bioactive fillers based on calcinated nanosized hydroxyapatite (HAp) and 
Mg-doped hydroxyapatite (Mg-HAp). HAp and Mg-HAp powders were synthesized 
hydrothermally. Mechanical properties: hardness by Vickers (HV) and flexural strength 
(Fs) were tested initially and after being stored for 28 days in simulated body fluid 
(SBF). The experimental composites with HAp and Mg-HAp particles showed no 
statistically significant difference in HV compared to the control (p>0.05) either 
initially or after storage. Although mean Fs values of modified composites tested 
initially were lower (62 MPa) than those of the control (72 MPa), after 28 days of 
storage in SBF Fs values were greater for modified composites (42 MPa control sample, 
48 MPa HAp, and Mg-HAp samples). In vitro bioactivity of BisGMA/TEGDMA 
composites with HAp and Mg-HAp particles after 28 days in SBF was not detected. 
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Introduction 
In the past decades, dental resin-based composites (RBCs) have been widely used 
as restorative materials for repairing damaged or decayed tooth structure [1]. They have 
replaced previously used amalgams, owing to their superior aesthetic properties such as 
adapting restoration color nuance to the one of the natural teeth. Dental composites 
typically consist of three main components: the organic matrix (bisphenol A glycerolate 
dimethacrylate (BisGMA), triethylene-glycol (TEGDMA), etc. resin with added 
initiators, accelerators, inhibitors, and stabilizers), inorganic filler particles, and the 
silane coupling agents [2]. While the commercially-used monomers have changed very 
little and only within the last two decades with the introduction of low-shrinkage, long-
chain monomers, significant improvements in mechanical properties of dental RBCs 
have been brought by changes in type, size, and distribution of the inorganic fillers. 
Polymerization shrinkage, on the other hand, is still a remaining issue. It causes micro-
gap formation at the tooth-restoration margins, enabling clinically invisible penetration 
of oral fluids and microorganisms toward the dental pulp, known as microleakage. 
Bacteria (e.g., Streptococcus mutans) metabolize sugars to lactic acid and therefore 
lowers pH [3]. Due to a decrease in pH value, hydroxyapatite in the tooth structure 
tends to demineralize causing caries [4]. Secondary caries is considered to be the most 
common reason for restoration failure and replacement [5,6]. Furthermore, bacterial 
metabolic by-products may cause pulpal inflammation and necrosis resulting in the loss 
of pulp vitality.  
One possible approach to reduce the risk of secondary caries development is to 
add bioactive agents that promote remineralization of tooth structure through calcium 
and phosphate ion release. In this regard, a wide range of calcium phosphates (CaP) 
such as hydroxyapatite (HAp), amorphous calcium phosphate (ACP), tetracalcium 
phosphate (TTCP) and mono- and dicalcium phosphates (MCPM and DCPA) have been 
studied as fillers in dental composites [7-18]. Nanostructured calcium-hydroxyapatite 
(HAp) presents as a desired component in dental materials due to its biocompatibility, 
bioactivity and chemical similarity to inorganic component of the teeth [19]. Moreover, 
HAp has intrinsic radio-opaque property and similar hardness to that of teeth [7]. 
During calcination and sintering, HAp undergoes a phase transition into β-tricalcium-
phosphate (β-TCP) which possesses higher resorb rate [20]. Doping HAp with 
magnesium ions (Mg-HAp) leads to stabilization of β-TCP phase during sintering, 
higher cell proliferation as well as to increased bioactivity, biocompatibility and 
stronger mechanical properties [21-23]. Furthermore, magnesium plays an essential role 
in cells such as stimulating cell growth and proliferation [23].  
CaP-resin composite materials developed so far were shown to be effective in 
remineralizing tooth lesions in vitro [24] as well as to inhibit the development of new 
lesions in situ [17]. Lezaja et al. [25] studied the effect of combining different HAp 
particles and conventional glass fillers in experimental BisGMA/TEGDMA composites 
on mechanical properties. It was reported that flexural strength was increased with the 
addition of HAp, but Vickers hardness decreased. To the best of our knowledge, effects 
of Mg-doped HAp fillers in dental composites have not been reported so far.  
As Mg-HAp has better mechanical properties compared to HAp, this study aimed 
to investigate the mechanical behavior of BisGMA/TEGDMA dental composites 
reinforced with conventional glass fillers combined with nano HAp and nano Mg-HAp 
particles. Based on the previously reported study by Lezaja et al. [25] a total amount of 
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73 wt. % reinforcement filler particles were used, with 10 % substitution with Mg-HAp 
or HAp calcinated powders. BisGMA/TEGDMA resin filled with only Ba-glass fillers 
was used as a control. HAp and Mg-HAp powders were obtained hydrothermally and 
characterized by the X-ray diffraction (XRD) and scanning electron microscopy (SEM) 
paired with energy dispersive X-ray analysis (EDX). Experimental composites were 
tested for flexural strength (Fs) and Vickers hardness (HV), initially 24 h after 
polymerization and after aging in simulated body fluid (SBF) for 28 days. Bioactivity of 
the prepared composites was monitored by SEM after being stored in SBF for 28 days. 
Materials and methods 
Hydroxyapatite and Mg-doped hydroxyapatite powders synthesis 
Nanosized calcium-hydroxyapatite (HAp) and calcium-hydroxyapatite doped 
with 5 mol.% magnesium (Mg-HAp) powders were obtained by a previously described 
modified hydrothermal method [26-28], starting from a solution of Ca(NO3)2∙4H2O 
(11.80 g), Na2H2EDTA∙2H2O (11.18 g), NaH2PO4∙2H2O (4.68 g) and urea (12.00 g). 
For the synthesis of Mg-HAp 5 mol. % of Ca was substituted with Mg ions. As Mg ion 
source was used Mg(NO3)2 ∙ 6H2O (0.641 g). The precursor solution was thermally 
treated in an autoclave at 160 °C for 3 hours, under p = 8 bar. Obtained participates 
were collected by vacuum filtration, flushed with deionized (DI) water and dried at 105 
°C. HAp and Mg-HAp powders were then calcinated for 4 hours at 1000 °C (heating 
rate of 20 °C/min). 
Composite paste preparation 
Experimental composites were prepared by a previously reported method [25] by 
mixing equal wt. % of BisGMA and TEGDMA resins with 0.2 wt. % of 
camphorquinone (CQ) and 0.8 wt. % of 2-(dimethyl)ethyl methacrylate (DMAEMA). 
All ingredients were purchased from Sigma-Aldrich Chemie GmbH, Munich, Germany. 
The content of fillers in experimental groups is shown in Table 1. Control conventional 
fillers were silanated barium glass particles with the average size of 0.7 µm (BaGlass, 
33% BaO, Esstech Inc, USA). HAp and Mg-HAp particles were used to replace 10 wt. 
% of glass fillers in experimental groups. 
Table 1. Composition of Experimental Composites. 
Group Filler content 
 Silanated 
Barium Glass 
(wt. %) 
HAp particles 
(wt. %) 
Mg-HAp 
particles 
(wt. %) 
Control  73 / / 
Hap 65.7 7.3 / 
Mg-HAp 65.7 / 7.3 
Sample preparation and storage for mechanical testing 
For Vickers hardness (HV) test, ten samples per group were prepared by using 
disc-shaped plastic molds, 5 mm in diameter and 2 mm deep. A Mylar strip was placed 
on a 1 mm thick glass slide, on top of which the mould was positioned and filled with 
composite. Top of the mould was covered with another strip and pressed with a glass 
slide to eliminate excess material and form a flat surface. Samples were then light-cured 
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with a light-emitting diode light-curing unit (LEDition, Ivoclar Vivadent, Schaan, 
Liechtenstein) at an intensity of 800 mW/cm2 for 40 s through the Mylar strip and the 
glass slide.  
For Fs testing, ten samples per group were prepared according to the ISO 
4049:2000 standard in steel molds with internal dimensions 2 mm x 2 mm x 25 mm. 
Each sample was cured for 4 x 40 s: in the middle, on the one end of the mold, then 
another end and lastly by moving the LED light-curing unit from one end to another and 
back.  
The samples were stored in DI water and kept in the incubator at 37 °C during 
the first 24 h, according to the ISO 2049:2000 standard. Afterward five samples per 
group were tested for HV and Fs, and the rest of the samples were immersed in 10 cm3 
Kokubo simulated body fluid (SBF) [29], the composition of which is shown in Table 2, 
and stored for 28 days in a water bath at 37 °C. SBF solution was replaced every five 
days. Another HV and Fs tests were carried out after aging for 28 days in SBF. 
Table 2. Composition of Kokubo simulated body fluid 
Ion Na+ K+ Ca2+ Mg2+ Cl- HCO3
- HPO4
2- SO4
2- 
c (mg/dm3) 142.0 5.0 2.5 1.5 147.8 4.2 1.0 0.5 
Characterization 
X-ray Diffraction Analysis 
Phase composition of HAp and Mg-HAp powders were determined by X-ray 
diffraction analysis (XRD) conducted on Ital Structure APD 2000 X-ray diffractometer 
with CuKα radiation (1.54 Å) in the 2θ angle ranging from 20° to 60° with a scan step 
0.02°. 
Scanning electron microscopy and energy dispersive X-ray analysis 
A scanning electron microscope (Tescan FE-SEM Mira 3 XMU, Tescan a.s., 
Brno, Czech Republic) was employed to characterize the morphology of the powders 
and the cross section of the experimental composites, operated at 20 keV. All samples 
were coated with gold using a sputter coater (Polaron SC503, Fisons Instruments, 
Ipswich, UK) before SEM analysis. To determine elemental composition energy 
dispersive X-ray (EDX) analysis was performed on Oxford Inca 3.2 coupled with SEM 
Jeol JSM 5800, operated at 20 keV. 
Hardness by Vickers 
Hardness by Vickers (HV) was measured by applying 500 g load for 5 s on an 
HV test machine (Buehler Indentament 1100 series, Buehler, Lake Bluff, IL). Three 
indentations were made on the bottom, non-irradiated side of each sample. 
Flexural strength 
Flexural strength (Fs) was measured using a three-point bending setup and a 
universal testing machine (Force Gauge PCE-FM200, Southampton, United Kingdom) 
at 1 mm/min speed until fracture. Fs was determined using the equation: 
𝐹𝑠 =
3𝐹𝑙
2𝑏ℎ2
(1) 
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where F is the maximum load measured before fracture, l is a distance between 
supports (20 mm), h is the sample height, and b is the sample width.  
In vitro bioactivity 
Apatite-forming ability of the composites was evaluated in Kokubo simulated 
body fluid (SBF). HAp, Mg-HAp, and control samples were soaked in 10 cm3 SBF at 
37 °C for 28 days. SBF solution was replaced every five days. After being soaked, 
samples were removed from SBF, gently rinsed with DI water three times, dried at 
room temperature for 24 h then stored in a desiccator. Morphology of the samples' 
surface was examined by SEM (Tescan FE-SEM Mira 3 XMU, Tescan a.s., Brno, 
Czech Republic). 
Statistical analysis  
Statistical analysis was performed in the software package Minitab Express 
(Minitab Inc. State College, PA, USA). Data for HV were analyzed using two-way 
analysis of variance (ANOVA) for the factors "materials" and "time" with the 
interaction between the two factors included. The level of significance was set at 0.05. 
Results 
EDX analysis 
Results of the EDX analysis of the powders are shown in Table 3. The results 
present average arithmetical value of three measurements of different surface areas of 
the sample at the 1000 times magnification. The presence of magnesium as doping 
species in Mg-HAp sample was confirmed. The Ca/Pa ratios in HAp, and Mg-HAp 
powders were less than the stoichiometric ratio of hydroxyapatite (1.67), implying that 
obtained hydroxyapatites were calcium-deficient, and expected to undergo a phase 
transition into -tricalcium phosphate (−TCP) when heated.  
Table 3. Elemental composition of obtained powders 
Sample Ca, at.% P, at.% Mg, at.% Ca/P ratio 
HAp 12.84 8.64 - 1.49 
Mg-HAp 11.59 8.00 0.27 1.45 
 
XRD analysis 
The XRD patterns of the HAp and Mg-HAp samples before calcination show 
peaks suggesting that monophasic calcium-hydroxyapatite powders were obtained (Fig. 
1 a,b) according to JCPDS 9‒432. After calcination at 1000 °C XRD patterns suggest 
that hydroxyapatite (HAp) underwent a phase transition into −tricalcium phosphate 
(−TCP) (Fig. 1 c,d). In the case of calcinated HAp sample (Fig. 1c) HAp phase was 
dominant, and a small amount was transformed into −TCP, while in the case of 
calcinated Mg-HAp sample biphasic powder with dominant −TCP phase was obtained 
(Fig. 1d). The increased amount of −TCP phase may be contributed to the presence of 
Mg ions in the Mg-HAp sample. 
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Fig. 1. XRD patterns of a) HAp powder; b) Mg-HAp powder; c) HAp calcinated at 1000 
°C; d) Mg-HAp calcinated at 1000 °C. 
SEM analysis 
The SEM micrographs of the HAp and Mg-HAp powders (Fig. 2 a,b) show that 
in both cases relatively uniform spherical agglomerates were obtained. In the case of 
HAp sample (Fig. 2a), these spherical particles are around 1,5 µm in size and consist of 
nano-rods. The spherical agglomerates of Mg-HAp (Fig. 2b) are noticeably rounder 
with more densely packed nano-rods. After calcination in both samples agglomerates 
were reduced in size and densified due to grain formation (Fig. 2 c,d). Fig. 3 shows 
cross sections of experimental composites with typical microstructure for dental 
composites. In the control sample conventional Ba-glass particles are visible in 
BisGMA/TEGDMA resin (Fig. 3a). In the case of modified experimental composites, 
round Mg-HAp and HAp particles are also present, relatively uniformly distributed 
inorganic matrix with no tendency to agglomerate (Fig. 3b and 3c respectively). 
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Fig. 2. SEM images of a) HAp particles; b) Mg-HAp particles; c) calcinated HAp 
powder; d) calcinated Mg-HAp powder. 
 
Fig. 3. SEM images of cross section of a) control sample; b) Mg-HAp sample; c) HAp 
sample. 
278 Metall. Mater. Eng. Vol 24 (4) 2018 p. 271-281 
 
In vitro bioactivity 
In vitro bioactivity is defined as the ability of a material to form apatite layer on 
its surface when submerged in SBF. Dental composites containing bioactive CaP 
particles were reported to be in vitro bioactive [7, 18]. Santos et al. [7] have shown that 
dental composites containing silanized hydroxyapatite particles are in vitro bioactive 
after being stored for 4 weeks in SBF. Aljabo et al. [18] have monitored in vitro 
bioactivity of dental composites containing equal masses of β-tricalcium phosphate (β-
TCP) and monocalcium phosphate monohydrate (MCPM) for 12 weeks in SBF. 
Experimental composites containing HAp and Mg-HAp particles tested in this study did 
not show any bioactive phenomenon after being stored for 28 days in SBF (Fig. 4). This 
is probably caused by the high quantity of Ba-glass filler, which is not bioactive.  
 
Fig. 4. Sample surface after 28 days in SBF  a) control; b) Mg-HAp sample; c) HAp 
sample. 
Hardness by Vickers (HV) 
HV test results are shown in Fig. 5 present average arithmetical value for five 
samples per group, tested initially and after aging in SBF for 28 days. Two-way 
ANOVA showed statistically significant differences for the factor "material" 
(p=0.0149), but not for the factor "time" (p=0.2877). The interaction between the two 
factors was not significant (p=0.1838) indicating no differences for each material at two 
periods (initially and after 28 days). Additional one-way ANOVA with Tukey's post hoc 
test was performed to analyze the differences between materials at both periods 
separately. Only marginal statistical significance was found between Mg-HAp and HAp 
groups initially (p=0.05), where mean HV values for composite reinforced with Mg-
HAp particles were 12 % greater than those for HAp reinforced composite. As shown in 
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Fig. 5, substituting 10 wt. % of conventional glass fillers with HAp and Mg-HAp 
particles had no statistically significant difference (p>0.05) either initially or after 
storage. This is following a previously reported paper by Lezaja et al. [25]. 
Fig. 5. Hardness by Vickers of experimental composites; uppercase letters refer to the 
groups initially; lower case letters refer to the groups after 28 days. Groups that share 
the same letter are not significantly different (p>0.05). Bar indicates no significant 
difference between the two periods for each group (p>0.05). 
Flexural strength (Fs) 
Results of flexural strength (Fs) testing initially and after being stored for 28 days 
in SBF are shown in Fig. 6 and present average arithmetical values for five samples per 
group. Statistical analysis was not performed on Fs values due to an insufficient number 
of data and high standard deviation values. As shown in Fig. 6, the addition of HAp and 
Mg-HAp particles decreased flexural strength of composites tested initially (74 MPa for 
control, 62 MPa for HAp sample, 61 MPa for Mg-HAp sample). The decrease in Fs 
after aging is common for all composite samples and following previously reported 
papers [14, 25, 30]. Fs was less affected by aging when Mg-HAp or HAp particles were 
added. Control samples decreased in the mean value of Fs by 43 %, while mean Fs 
values for HAp and Mg-HAp samples decreased by 23 %. After 28 days stored in SBF, 
modified composites had higher mean values of flexural strength by 12 % than the 
control. 
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Fig. 6. Flexural strength of experimental composites. 
Conclusion 
Substitution of 10 wt. % conventional glass fillers with HAp and Mg-HAp 
powders had no statistically significant difference in hardness by Vickers (p>0.05) 
either initially or after storage in SBF for 28 days. The addition of HAp and Mg-HAp 
particles decreased flexural strength of composites tested initially, but it improved the 
stability of composites when stored in SBF. After being stored in SBF for 28 days, 
control sample mean values of Fs decreased by 43 %, while mean Fs values for HAp 
and Mg-HAp samples decreased by 23 %. Modified composites had 12 % higher 
flexural strength than the control after 28 days. In vitro bioactivity of 
BisGMA/TEGDMA composites with HAp and Mg-HAp particles after 28 days in SBF 
was not detected. 
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